Foker J E, Bass J L, Thompson T, Tilleli J A, Johnson D E
J Thorac Cardiovasc Surg. 1984 Feb;87(2):244-50.
Intracardiac fungal masses can develop following episodes of candidemia in premature infants with indwelling right atrial lines. We report the first premortem diagnosis and successful surgical removal of Candida-containing intracardiac masses in three premature infants. All had central venous lines and had been on systemic antibiotics prior to the development of candidemia. By echocardiography, two were pedunculated, solitary masses within the right atrium. Amphotericin B and 5-flucytosine for 21 to 42 days controlled the Candida sepsis, but the masses became increasingly mobile and did not decrease in size. In the third infant, large, irregular masses extended from the right atrium to the main pulmonary artery, and surgical removal was recommended 4 days after the start of antifungal therapy. In all three patients, the masses were nearly the size of the main pulmonary artery and presumably contained viable organisms. Removal was accomplished with the aid of cardiopulmonary bypass for two and inflow stasis for one infant weighing only 1,300 gm. The masses were filled with viable Candida organisms. All patients tolerated the operation well and have been followed up for 1 to 3.6 years without evidence of recurrent Candida infection. The case of a fourth infant, weighing 1,320 gm, is also reported. This infant had a bacteria-containing intra-atrial mass, which was removed successfully with the aid of inflow occlusion. This report documents the following points: (1) Echocardiography provides a noninvasive method of diagnosing the development of intracardiac masses and should be performed in infants who have had candidemia and a central venous line. (2) Prolonged systemic antifungal therapy does not appear to either sterilize or promote regression of the masses. (3) The masses can be safely removed, even in the premature infant, with either inflow stasis or cardiopulmonary bypass. (4) Surgical removal is an effective component of the treatment of infection in these infants.
对于留置右心房导管的早产儿,念珠菌血症发作后可形成心内真菌团块。我们报告了3例早产儿心内含念珠菌团块的生前诊断及成功手术切除病例。所有患儿均有中心静脉导管,在念珠菌血症发生前均接受过全身抗生素治疗。超声心动图显示,2例患儿右心房内有带蒂的孤立团块。两性霉素B和5-氟胞嘧啶治疗21至42天控制了念珠菌败血症,但团块活动度增加且大小未减小。第3例患儿,大的不规则团块从右心房延伸至主肺动脉,抗真菌治疗开始4天后建议手术切除。所有3例患儿的团块几乎与主肺动脉大小相当,推测含有存活的病原体。2例患儿在体外循环辅助下完成切除,1例体重仅1300克的患儿采用流入道血流阻断完成切除。团块内充满存活的念珠菌。所有患儿手术耐受性良好,随访1至3.6年无念珠菌感染复发迹象。还报告了第4例体重1320克患儿的病例。该患儿心房内有含细菌团块,通过流入道阻断成功切除。本报告证明了以下几点:(1)超声心动图为诊断心内团块形成提供了一种非侵入性方法,对于有念珠菌血症和中心静脉导管的婴儿应进行该项检查。(2)长期全身抗真菌治疗似乎既不能使团块灭菌也不能促进其消退。(3)即使是早产儿,采用流入道血流阻断或体外循环均可安全切除团块。(4)手术切除是这些患儿感染治疗的有效组成部分。